Fabio Cominelli, MD, PhD
Showing of 6 results
Research Discoveries Boost Personalized Treatment for IBD
Fabio Cominelli, MD discusses how his team of researchers discovered the specific blockade of interleukin-18 can reduce disease severity in colitis and new personalized therapies to put IBD in permanent remission.
Does the Microbiome Hold the Key to Treating Inflammatory Bowel Disease?
Gut instincts - Innovations in Digestive Health | Winter 2020
Suppressing Inflammation in IBD Patients
UH Digestive Health Institute explores new IBD treatment using IL-1 targeted therapy UH Innovations in Digestive Health - Fall 2018 Fabio Cominelli, MD For 25 years, researchers have studied interleukin-1 (IL-1), a highly active proinflammatory...
Investigating Treatments for Inflammatory Bowel Disease
UH Inflammatory Bowel Disease Center advances clinical research and therapies to treat Crohn's disease and ulcerative colitis UH Digestive Health Institute - Winter 2018 Fabio Cominelli, MD, PhD Maneesh Dave, MD, MPH Jeffrey Katz, MD A...
Excellence in Leading Edge Crohn's Disease Research
UH Digestive Disease Institute | Janaury 2017
UH Gastroenterologist Leading New NIH-Funded Digestive Diseases Research Core Center
Innovative care for Inflammatory and Metabolic Digestive Disease UH Digestive Health Institute - January 2016 Fabio Cominelli, MD, PhD Fabio Cominelli, MD, PhD, Chief Scientific Officer, UH Digestive Health Institute; Chief, Division of...